Brand Intelligence Graphcompany
Company Overview
About Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Business Model & Competitive Advantage
Revvity reported approximately $2.9 billion in revenue in FY2024, following the divestiture of its Applied, Food, and Enterprise Services segment (sold to New Mountain Capital in 2023 for $2.45 billion) to sharpen focus on higher-growth life science and diagnostics markets. The Diagnostics segment's newborn screening franchise — screening for ~50+ metabolic disorders using Revvity's NeoBase kits and Natus instruments — has near-monopoly characteristics in many countries where national programs are standardized on Revvity platforms. The Life Sciences segment serves pharmaceutical and biotech researchers with automated liquid handling, imaging systems, and genomics tools.
Competitive Landscape 2025–2026
Revvity's strategic priority is integrating its informatics capabilities (Symphony, OneSource laboratory software) with its instrument platforms to create connected lab ecosystems. The company's EUROIMMUN diagnostics business, acquired in 2017 for €1.3 billion, is a leading provider of autoimmune and infectious disease diagnostics in Europe, strengthening its clinical diagnostics presence.
Recent Activity
View all →Key Differentiators
Market Leader
Revvity is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $2.9B in revenue, Revvity operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Compare Revvity with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Revvity? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Revvity Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Revvity vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →